Hypertension drugs Market Anticipated to Grow at a CAGR of 1.12% during 2016-2024

New York, USA, 2018-Dec-06 — /EPR Network/ —  According to Goldstein Research, Hypertension Drugs Market is expected to reach USD 33.1 billion by 2024, growing at a CAGR of 1.12% over the forecast period 2016-2024. The rising geriatric population across the globe is driving the growth of the market. As per WHO statistics, nearly 22% of adults aged over 18yrs have increased blood pressure and nearly 52%  American adults suffering from high blood pressure have their condition under control. Further, based on segmentation, systematic hypertension drugs segment accounted for the highest market share of 85.0% in 2016.

Global Hypertension Drugs Market is largely dominated by the North America region with a market share of 42.0% in 2016. The US has recently experienced growth in sales of hypertension drugs due to the spread of new disease-modifying therapies.

Browse Full Report: 


Market Segmentation

On the basis of our in-depth analysis, Global Hypertension drugs Market can be segmented as follows:

By Analysis Basis

  • Systemic Hypertension Drugs
  • Pulmonary Hypertension Drugs

By Therapy Type

  • Calcium Channel Blockers
  • Diuretics
  • Beta Blockers Vasodilators
  • Angiotensin Converting Enzyme Inhibitor
  • Alpha Blockers
  • Angiotensin Receptor Blockers
  • Renin Inhibitors

By Region

  • North America Hypertension drugs Market Analysis, 2016-2024
  • Europe Hypertension drugs Market Analysis, 2016-2024
  • Middle East And Africa Hypertension drugs Market Analysis, 2016-2024
  • Latin America Hypertension drugs Market Analysis, 2016-2024
  • Asia Pacific Hypertension drugs Market Analysis, 2016-2024
  • Rest Of The World Hypertension drugs Market Analysis, 2016-2024

 Download Exclusive Sample Report: 


“Global Hypertension drugs Market Outlook 2024” contains detailed overview of the global hypertension drugs market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by analysis basis, therapy type and geography.

The Global Hypertension Drugs Market Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of hypertension drugs market report will help the clients to assess their business strategies as per the competitive environment in the market space.

Major players of the global hypertension drugs market discussed in the report are: Lupin Limited, Novartis AG, Sun Pharmaceuticals LLC, Daiichi – Sankyo, Pfizer Inc., Sanofi S.A, AstraZeneca Plc., Johnson & Johnson Ltd., BoehringerIngelheim, and Merck & Co, Roche, Abbott, GlaxoSmithKline plc., AstraZeneca, Bayer AG, Gilead, Actelion, Symplmed Pharmaceuticals, Takeda Pharmaceuticals, United Therapeutics, Valeant Pharmaceuticals, XOMA, Yuhan, Ono Pharmaceutical, Northern Therapeutics, Mast Therapeutics, EigerBioPharmaceuticals,etc.

Further, Global Hypertension Drugs Market Report encompasses the major trends & growth opportunities, market dynamics and other growth factors. The Hypertension drugsMarket outlook also comprises of key challenges for the market players, risk analysis, SWOT Analysis, USP Analysis, BPS analysis, and Market Attractiveness. The report also includes the expert analysis which provides a complete overview of the market post analysis of the economic, political, environmental & social factors of each region and country.

Hypertension Drugs Market is growing on the basis of advancement in mentioned below industries:

Stress Management Supplements Market
Various factors are impacting the rising stress level among the people. The working class population has been reported to have maximum cases of stress problem and thus there is high demand of anti-stress pills. Stress Management Supplements Market is expected to grow at a CAGR of 2.3% during the 2017-2025 period to reach USD 16.7 billion by 2025.  Stress has become a common issue across Globe. Where the  Australia Stress Management Supplements Market is expected to grow at a CAGR of 2.26% during the 2017-2025 period to reach USD 16.7 billion by 2025 and Europe Stress Management Supplements Market is anticipated to reach a market size of USD 65.23 billion by 2025, growing at 30.0% CAGR over the forecast period 2017-2025.

Brain Health Supplements Market

Brain Health Supplement Market is expected to reach USD 3.2 billion by 2024 from an estimated market size of USD 1.8 billion in 2016, growing at a CAGR of 7.4% over the forecast period 2016-2024. Increasing ageing population and the related health problems such as Alzheimer and dementia are majorly driving the growth of brain health supplements market


Matched content

Editor’s pick

Express Press Release Distribution